US Stock MarketDetailed Quotes
DERM Journey Medical
- 3.615
- +0.035+0.98%
Trading Apr 19 09:44 ET
72.06MMarket Cap-17214P/E (TTM)
3.615High3.500Low2.26KVolume3.500Open3.580Pre Close7.94KTurnover0.03%Turnover RatioLossP/E (Static)19.93MShares8.11052wk High3.54P/B29.82MFloat Cap1.02052wk Low--Dividend TTM8.25MShs Float10.200Historical High--Div YieldTTM3.21%Amplitude1.020Historical Low3.514Avg Price1Lot Size
Journey Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 138.72%5.24M | -330.66%-16.52M | 357.44%18.75M | 220.27%3.97M | -208.14%-956K | -520.54%-13.53M | -19.65%-3.84M | -202.53%-7.28M | 55.63%-3.3M | -35.05%884K |
| Net income from continuing operations | 87.00%-3.85M | 79.86%-2.14M | 266.56%16.79M | -11.09%-8.36M | -635.56%-10.14M | 32.65%-29.63M | 51.07%-10.64M | 5.32%-10.08M | 36.55%-7.53M | -614.18%-1.38M |
| Depreciation and amortization | -11.68%3.86M | -32.85%838K | -19.54%836K | 4.91%1.09M | 5.00%1.09M | 70.51%4.37M | 143.27%1.25M | 52.79%1.04M | 36.35%1.04M | 71.74%1.04M |
| Other non cash items | -14.89%709K | -98.80%2K | 7.80%235K | 54.55%357K | -47.00%115K | -95.84%833K | -95.72%167K | -98.03%218K | -95.20%231K | -1.81%217K |
| Change In working capital | -126.75%-1.66M | -526.68%-15.69M | 756.25%411K | 198.24%6.42M | 2,230.74%7.2M | -57.94%6.19M | 20.08%3.68M | -99.49%48K | -1.82%2.15M | 191.51%309K |
| -Change in receivables | 333.29%12.55M | -14,170.59%-7.18M | 10,538.55%8.83M | 320.44%10.43M | 105.83%466K | -800.52%-5.38M | -99.40%51K | 101.50%83K | 195.50%2.48M | -2,150.00%-8M |
| -Change in inventory | 126.66%3.95M | -23.62%818K | 38.76%1.14M | 1,223.81%1.11M | 476.50%881K | 120.62%1.74M | -38.87%1.07M | -69.53%823K | 100.70%84K | 73.62%-234K |
| -Change in prepaid assets | 67.97%-279K | -12.55%-2.66M | 837.63%872K | 18.85%681K | 0.24%832K | -12.53%-871K | -149.68%-2.37M | 111.98%93K | 19.87%573K | 75.85%830K |
| -Change in payables and accrued expense | -265.80%-17.8M | -234.60%-6.64M | -1,014.56%-10.41M | -497.11%-5.78M | -34.58%5.04M | -54.13%10.73M | 172.27%4.94M | -106.88%-934K | -105.91%-968K | 2,783.90%7.7M |
| -Change in other current assets | --0 | --0 | --0 | --0 | --0 | 138.19%55K | -98.66%8K | 101.17%7K | 136.36%8K | 126.45%32K |
| -Change in other current liabilities | 12.63%-83K | -4.55%-23K | 4.17%-23K | 8.00%-23K | 41.67%-14K | -13.10%-95K | 0.00%-22K | -4.35%-24K | -4.17%-25K | -60.00%-24K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 138.72%5.24M | -330.66%-16.52M | 357.44%18.75M | 220.27%3.97M | -208.14%-956K | -520.54%-13.53M | -19.65%-3.84M | -202.53%-7.28M | 55.63%-3.3M | -35.05%884K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 75.00%-5M | 0 | 0 | 0 | 75.00%-5M | -100.00%-20M | 0 | 0 | 0 | -20M |
| Net intangibles purchase and sale | 75.00%-5M | --0 | --0 | --0 | 75.00%-5M | -100.00%-20M | --0 | --0 | --0 | ---20M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 75.00%-5M | --0 | --0 | --0 | 75.00%-5M | -100.00%-20M | --0 | --0 | --0 | ---20M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -129.19%-4.8M | 1,926.37%19.21M | -372.34%-10.98M | -11,890.99%-13.09M | -99.54%52K | -68.96%16.46M | -97.02%948K | -64.04%4.03M | -81.98%111K | 21.03%11.37M |
| Net issuance payments of debt | -152.95%-8.95M | 1,482.28%15M | -375.00%-11M | ---13M | -99.56%52K | 234.50%16.9M | 16.75%948K | -43.18%4M | --0 | 763.94%11.95M |
| Net common stock issuance | --4.49M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | -14.79%121K | --96K | -29.03%22K | ---- | ---- | 1,928.57%142K | --0 | --31K | ---- | ---- |
| Net other financing activities | 19.49%-471K | ---380K | --0 | ---- | ---- | 83.50%-585K | --0 | --0 | --0 | 56.76%-585K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -129.19%-4.8M | 1,926.37%19.21M | -372.34%-10.98M | -11,890.99%-13.09M | -99.54%52K | -68.96%16.46M | -97.02%948K | -64.04%4.03M | -81.98%111K | 21.03%11.37M |
| Net cash flow | ||||||||||
| Beginning cash position | -34.80%32M | -29.07%24.75M | -55.48%16.98M | -36.85%26.1M | -34.80%32M | 495.21%49.08M | 60.87%34.89M | 213.26%38.14M | 117.55%41.33M | 495.21%49.08M |
| Current changes in cash | 73.28%-4.56M | 193.14%2.69M | 338.97%7.77M | -185.95%-9.12M | 23.82%-5.9M | -141.82%-17.08M | -110.54%-2.89M | -134.17%-3.25M | 53.25%-3.19M | -172.08%-7.75M |
| End cash Position | -14.26%27.44M | -14.26%27.44M | -29.07%24.75M | -55.48%16.98M | -36.85%26.1M | -34.80%32M | -34.80%32M | 60.87%34.89M | 213.26%38.14M | 117.55%41.33M |
| Free cash flow | 100.72%240K | -330.66%-16.52M | 357.44%18.75M | 220.27%3.97M | 68.84%-5.96M | -175.30%-33.53M | 12.94%-3.84M | -328.86%-7.28M | 55.63%-3.3M | -1,504.56%-19.12M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg